Vermillion EBITDA 2006-2019 | VRML

Vermillion ebitda from 2006 to 2019. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Vermillion Annual EBITDA
(Millions of US $)
2018 $-11
2017 $-10
2016 $-14
2015 $-19
2014 $-19
2013 $-9
2012 $-9
2011 $-18
2010 $-14
2009 $-5
2008 $-13
2007 $-20
2006 $-21
2005 $-26
Vermillion Quarterly EBITDA
(Millions of US $)
Q2 2019 $-4
Q1 2019 $-4
Q4 2018 $-3
Q3 2018 $-2
Q2 2018 $-3
Q1 2018 $-3
Q4 2017 $-3
Q3 2017 $-2
Q2 2017 $-2
Q1 2017 $-2
Q4 2016 $-3
Q3 2016 $-3
Q2 2016 $-4
Q1 2016 $-5
Q4 2015 $-5
Q3 2015 $-5
Q2 2015 $-5
Q1 2015 $-4
Q4 2014 $-4
Q3 2014 $-6
Q2 2014 $-6
Q1 2014 $-4
Q4 2013 $-2
Q3 2013 $-2
Q2 2013 $-2
Q1 2013 $-3
Q4 2012 $-1
Q3 2012 $-2
Q2 2012 $-4
Q1 2012 $-2
Q4 2011 $-3
Q3 2011 $-5
Q2 2011 $-6
Q1 2011 $-4
Q4 2010 $-4
Q3 2010 $-4
Q2 2010 $-4
Q1 2010 $-3
Q4 2009
Q3 2009
Q2 2009
Q1 2009
Q4 2008 $-4
Q3 2008 $-3
Q2 2008 $-3
Q1 2008 $-4
Q4 2007 $-5
Q3 2007 $-4
Q2 2007 $-6
Q1 2007 $-5
Q4 2006 $-6
Q3 2006 $-5
Q2 2006 $-6
Q1 2006 $-4
Q4 2005 $-6
Q3 2005 $-6
Q2 2005 $-7
Q1 2005 $-7
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.061B $0.003B
Vermillion, Inc. is engaged in the discovery, development and commercialization of novel diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. The Company has diagnostic programs in oncology, hematology, cardiology and women's health. Its tests are intended to guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, to perform additional testing, or to assist in the selection of therapy. Vermillion also intends to address clinical questions related to early disease detection, treatment response, monitoring of disease progression, prognosis and others. Its lead product includes the OVA1 ovarian tumor triage test, which addresses presurgical identification of women who are at high risk of having a malignant ovarian tumor. In addition to the OVA1 Test, Vermillion has development programs in other clinical aspects of ovarian cancer as well as in peripheral arterial disease. Vermillion, Inc. is based in Fremont, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $118.152B 24.47
Intuitive Surgical (ISRG) United States $63.444B 49.86
Edwards Lifesciences (EW) United States $48.839B 44.35
Fresenius Medical Care AG KGaA (FMS) Germany $22.779B 15.41
IDEXX Laboratories (IDXX) United States $21.852B 52.85
Olympus (OCPNY) Japan $21.592B 0.00
DexCom (DXCM) United States $18.130B 162.36
Teleflex (TFX) United States $15.332B 31.13
Sysmex ADR (SSMXY) Japan $15.303B 41.19
SONOVA HOLDING (SONVY) Switzerland $14.797B 0.00
Hologic (HOLX) United States $12.446B 19.08
STERIS (STE) Ireland $12.351B 27.31
Varian Medical Systems (VAR) United States $11.361B 26.89
ABIOMED (ABMD) United States $9.917B 53.96
Masimo (MASI) United States $7.625B 45.53
Penumbra (PEN) United States $5.732B 187.21
SARTORIUS AG (SARTF) Germany $5.614B 49.28
Elekta AB (EKTAY) Sweden $5.564B 42.84
Globus Medical (GMED) United States $5.522B 34.18
Integra LifeSciences Holdings (IART) United States $5.027B 21.60
Wright Medical Group (WMGI) Netherlands $3.728B 327.00
LivaNova (LIVN) United Kingdom $3.549B 25.55
Tandem Diabetes Care (TNDM) United States $3.390B 0.00
Nevro (NVRO) United States $3.274B 0.00
Cantel Medical (CMD) United States $3.045B 30.75
Nihon Kohden (NHNKY) Japan $2.443B 24.58
Integer Holdings (ITGR) United States $2.422B 16.58
Glaukos (GKOS) United States $2.265B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.703B 33.53
Inogen (INGN) United States $1.519B 47.97
Veracyte (VCYT) United States $1.152B 0.00
Natus Medical (NTUS) United States $1.113B 26.76
Silk Road Medical (SILK) United States $1.073B 0.00
Mesa Laboratories (MLAB) United States $1.037B 38.44
Tactile Systems Technology (TCMD) United States $0.991B 113.26
OPKO Health (OPK) United States $0.978B 0.00
CryoLife (CRY) United States $0.872B 89.42
ORTHOFIX MEDICAL INC (OFIX) United States $0.849B 28.22
Accelerate Diagnostics (AXDX) United States $0.839B 0.00
Luminex (LMNX) United States $0.827B 0.00
Pacific Biosciences Of California (PACB) United States $0.717B 0.00
Intersect ENT (XENT) United States $0.673B 0.00
AxoGen (AXGN) United States $0.602B 0.00
AngioDynamics (ANGO) United States $0.568B 20.39
OrthoPediatrics (KIDS) United States $0.560B 0.00
Quotient (QTNT) Switzerland $0.516B 0.00
Si-Bone (SIBN) United States $0.455B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.441B 13.35
Sientra (SIEN) United States $0.436B 0.00
Alphatec Holdings (ATEC) United States $0.414B 0.00
GenMark Diagnostics (GNMK) United States $0.316B 0.00
Semler Scientific (SMLR) United States $0.303B 42.18
ViewRay (VRAY) United States $0.266B 0.00
IRadimed (IRMD) United States $0.264B 37.52
SeaSpine Holdings (SPNE) United States $0.260B 0.00
Stereotaxis (STXS) United States $0.248B 0.00
Accuray (ARAY) United States $0.247B 0.00
CRH Medical (CRHM) Canada $0.222B 61.82
Fluidigm (FLDM) United States $0.162B 0.00
RTI Surgical (RTIX) United States $0.147B 39.80
ConforMIS (CFMS) United States $0.138B 0.00
EDAP TMS S.A (EDAP) France $0.128B 63.00
T2 Biosystems (TTOO) United States $0.118B 0.00
Spectral Diagnostics (EDTXF) Canada $0.112B 0.00
Second Sight Medical Products (EYES) United States $0.110B 0.00
Neuronetics (STIM) United States $0.091B 0.00
Sensus Healthcare (SRTS) United States $0.063B 0.00
Apollo Endosurgery (APEN) United States $0.061B 0.00
TransEnterix (TRXC) United States $0.058B 0.00
Electromed (ELMD) United States $0.057B 29.22
Bioanalytical Systems (BASI) United States $0.055B 0.00
Ekso Bionics Holdings (EKSO) United States $0.045B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.045B 0.00
Xtant Medical Holdings (XTNT) United States $0.028B 0.00
Helius Medical Technologies (HSDT) United States $0.025B 0.00
Neovasc (NVCN) Canada $0.025B 0.00
Nuvectra (NVTR) United States $0.023B 0.00
Ra Medical Systems (RMED) United States $0.021B 0.00
ReWalk Robotics (RWLK) Israel $0.019B 0.00
American Shared Hospital Services (AMS) United States $0.015B 20.88
Restoration Robotics (VERO) United States $0.014B 0.00
Nanovibronix (NAOV) United States $0.013B 0.00
DarioHealth (DRIO) Israel $0.010B 0.00
OBALON THERPTCS (OBLN) United States $0.009B 0.00
Lianluo Smart (LLIT) China $0.008B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.008B 0.00
Avinger (AVGR) United States $0.007B 0.00
ENDRA Life Sciences (NDRA) United States $0.007B 0.00
Dynatronics (DYNT) United States $0.007B 0.00
Micron Solutions (MICR) United States $0.006B 0.00
Viveve Medical (VIVE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Allied Healthcare Products (AHPI) United States $0.004B 0.00
Sunshine Heart Inc (CHFS) United States $0.002B 0.00
InspireMD (NSPR) Israel $0.002B 0.00